Rhythm Pharmaceuticals (RYTM) Earnings Date & Reports

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

RYTM is expected to report earnings to fall 1.98% to -81 cents per share on August 04

Rhythm Pharmaceuticals RYTM Stock Earnings Reports

Q2'26

Est.

$-0.81

Q1'26

Est.

$-0.83

Q4'25

Beat

by $0.09

Q3'25

Missed

by $0.11

Q2'25

Missed

by $0.08

The last earnings report on May 05 showed earnings per share of -82 cents, meeting the estimate of -82 cents. With 487.22K shares outstanding, the current market capitalization sits at 6.96B.

View a ticker or compare two or three

Compare

RYTM

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for RYTM